A phase I study to assess the mass balance, excretion, and pharmacokinetics of [(14)C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.
about
A phase I study to assess the mass balance, excretion, and pharmacokinetics of [(14)C]-ixazomib, an oral proteasome inhibitor, in patients with advanced solid tumors.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
A phase I study to assess the ...... ts with advanced solid tumors.
@en
A phase I study to assess the ...... ts with advanced solid tumors.
@nl
type
label
A phase I study to assess the ...... ts with advanced solid tumors.
@en
A phase I study to assess the ...... ts with advanced solid tumors.
@nl
prefLabel
A phase I study to assess the ...... ts with advanced solid tumors.
@en
A phase I study to assess the ...... ts with advanced solid tumors.
@nl
P2093
P2860
P1476
A phase I study to assess the ...... ts with advanced solid tumors.
@en
P2093
Bingxia Wang
Dale R Shepard
Karthik Venkatakrishnan
Michael J Hanley
Mihaela Plesescu
Sandeepraj Pusalkar
Steven Zhang
Swapan Chowdhury
Xiaoquan Zhang
P2860
P2888
P304
P356
10.1007/S10637-017-0509-1
P50
P577
2017-09-21T00:00:00Z